MedTrace Logo

To Evaluate IOL Position, Clinical Outcome of PanOptix in High Myopic Cataract Patients

NCT05042856 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-09-21

No results posted yet for this study

Summary

To evaluate IOL position, clinical outcome of PanOptix in high myopic cataract patients

Conditions

  • Cataract
  • High Myopia

Interventions

PROCEDURE

PanOptix IOL implantation

All the patients will be bilaterally implanted with PanOptix IOL，one eye will be randomized selected for monocular analysis of each patient.

Sponsors & Collaborators

  • Wenzhou Medical University

    lead OTHER

Principal Investigators

  • yune zhao, MD · Wenzhou Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05042856 on ClinicalTrials.gov